ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Jul 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
September 2025
Nuclear Technology
August 2025
Fusion Science and Technology
Latest News
INL makes a case for eliminating ALARA and setting higher dose limits
A report just released by Idaho National Laboratory reviews decades of radiation protection standards and research on the health effects of low-dose radiation and recommends that the current U.S. annual occupational dose limit of 5,000 mrem be maintained without applying ALARA—the “as low as reasonably achievable” regulatory concept first introduced in 1971—below that threshold.
Noting that epidemiological studies “have consistently failed to demonstrate statistically significant health effects at doses below 10,000 mrem delivered at low dose rates,” the report also recommends “future consideration of increasing this limit to 10,000 mrem/year with appropriate cumulative-dose constraints.”
Technical Session|Panel|Sponsored by RPD
Monday, June 17, 2024|1:00–2:45PM PDT|Jasmine D
Session Chair:
John H. Jackson (INL)
Alternate Chair:
Massimiliano Fratoni
Session Organizer:
Abdalla Abou-Jaoude (INL)
The MARVEL reactor demonstration is proceeding to deployment with manufacturing underway on long-lead items. This panel will provide a status update on the overall project along with an overview of the TREX-C facility (TREAT Reactor Experiment Cell). A discussion of the safety review for MARVEL, including hazard evaluation will be provided. Additionally an overview of the MARVEL utilization plan will be presented to highlight how MARVEL can be leveraged as a testbed for future users.
To join the conversation, you must be logged in and registered for the meeting.
Register NowLog In
